Replies to post #287764 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

We have been disappointed by Peregrine before. It may happen again. Or, just maybe the triple path of Bavi-immunotherapy, bavi-exosome diagnostic, and Avid growing profits may save the day. I know the hour is very late to prevent the RS, but it is not actually too late.

Wouldn't it be loverly,

Paul

[sulaco]

Yeah, the final kicker will be the exosome cancer test that nobody saw coming - and that provokes the buyout